York University Secures Major CIHR Funding for Cutting-Edge Mental Health Research Projects

In a significant boost to Canadian health research, York University researchers have received nearly $2.8 million from the Canadian Institutes of Health Research (CIHR) to lead innovative projects addressing critical gaps in mental health care. Announced on February 27, 2026, these grants from CIHR's Project Grant competition highlight York's Faculty of Science's pivotal role in advancing neuroscience and AI-driven solutions for mental health challenges. The funding supports three projects, two led directly by York faculty and one co-led, focusing on gene regulation, executive brain functions linked to psychiatric disorders, and AI for posttraumatic stress disorder (PTSD) treatment.

CIHR, Canada's federal funding agency for health research, prioritizes initiatives like these through its Institute of Neurosciences, Mental Health and Addiction (INMHA), which targets brain health, addiction, and mental wellness. With mental health issues affecting 1 in 5 Canadians annually and rising among youth, these projects come at a crucial time.

Project Spotlight: Revolutionizing Gene Regulation with Biotin Pulse Labeling

Led by Emanuel Rosonina, associate professor in the Department of Biology, this $921,825 five-year project examines transcription dynamics using a novel biotin pulse labeling (BPL) technique developed by his team. Traditional methods offer static snapshots of protein-DNA interactions, but BPL captures real-time changes, revealing how cells decide which genes to activate and when.

Disruptions in gene expression underlie many diseases, including mental health disorders like depression and schizophrenia where regulatory errors contribute to pathology. Rosonina's work, building on prior studies of sumoylation in transcription factors, aims to pinpoint these mechanisms, potentially leading to targeted therapies. By understanding dynamic gene control, researchers can better address conditions rooted in faulty expression, such as those involving neurotransmitter genes in the brain.

• Key Innovation: Real-time tracking of protein-DNA binding via BPL.
• Potential Impact: New insights into disease-linked gene dysregulation.
• Broader Relevance: Links to neurodevelopmental and psychiatric conditions.

Decoding Executive Control in the Brain: Jeffrey Schall's Neuro-Computational Study

Jeffrey Schall, professor in Biology and Canada Research Chair in Translating Neuroscience, received $1,055,700 over five years to map the functional architecture of the frontal cortex's dorsal and cingulate regions. These areas govern planning, decision-making, impulse control, and behavioral adaptation—functions often impaired in disorders like ADHD, OCD, and schizophrenia.

Using advanced imaging and neural recording, Schall's lab will track signals during tasks involving error monitoring and response inhibition, akin to stop-signal paradigms used in clinical settings. His prior work on gaze control and beta-bursts in medial frontal cortex provides a foundation, showing how the brain exerts executive oversight. This could refine diagnostics and interventions for psychiatric patients struggling with cognitive flexibility.

Schall's research translates basic neuroscience to clinical applications, aligning with CIHR's goal of bridging lab findings to patient care. For higher education, it underscores opportunities in computational neuroscience for students pursuing research jobs in brain health.

TRAUMIRA: AI-Powered Support for PTSD Recovery

Co-principal investigator Divya Sharma from Mathematics & Statistics joins Unity Health Toronto in a $823,905 project adapting MIRA, an AI mental health assistant from the Mood Disorders Society of Canada, into TRAUMIRA—a trauma-focused tool for PTSD. MIRA already navigates users to supports; TRAUMIRA adds personalized coping strategies, PTSD education, and recovery resources, co-designed with lived-experience contributors, clinicians, and technologists.

PTSD affects 1 in 10 Canadians, with access barriers exacerbating the crisis. This ethical AI complements therapy, offering anonymous, scalable aid amid waitlists. Sharma's IMPACT-AI Lab expertise in equitable ML ensures bias mitigation, vital for diverse populations. Try MIRA to see its potential.

• Features: Coping tools, education, referrals.
• Ethical Focus: Lived-experience co-design.
• Goal: Bridge care gaps scalably.

The Mental Health Crisis in Canada: Why This Funding Matters

Canada faces a mental health emergency: 1 in 5 adults experience illness yearly, rising to 1 in 2 by age 40; youth rates for mood/anxiety disorders have surged, with 15% of 15+ meeting criteria but many unmet needs (41% partially/not met). Suicide claims 4,000 lives annually, second-leading cause for youth. Post-pandemic, psychosis diagnoses in Ontario teens climbed.

CIHR's INMHA prioritizes these via equitable, innovative research. York's grants target root causes (gene/executive dysfunction) and delivery (AI), amplifying impact.

York University's Legacy in Mental Health Innovation

York leads nationally, e.g., $5.45M DIVERT Mental Health Platform ($2.55M CIHR + partners), training clinician-scientists in digital/equitable interventions for child/family mental health. Led by Rebecca Pillai Riddell, it spans 80+ partners, offering free training pan-Canada. Faculty of Health hosts labs like Developmental Disabilities Mental Health and Critical Perspectives on Mental Health.

Past CIHR: pharmacare's mental health links, hep C (substance ties). York's interdisciplinary approach positions it as a hub; check Rate My Professor for standout faculty.

CIHR's Strategic Priorities Align with York's Projects

CIHR's 2021-2031 plan emphasizes inclusive research; INMHA targets addiction/mental health via tech/equity. Recent youth mental health investments underscore urgency. York's gene/AI/neuro work fits, fostering transdisciplinary solutions.

Implications for Higher Education and Careers

These grants create training opps; York's platforms like DIVERT equip students for research assistant roles. Demand surges for neuroscientists/AI ethicists; explore higher ed jobs.

Photo by Jason Zhao on Unsplash

Future Outlook: Transforming Mental Health Care

Expect breakthroughs: dynamic gene tools for precision meds, frontal cortex maps for therapies, AI scaling PTSD support. With Canada's crisis (2/5 needs unmet), York's CIHR-funded innovations promise accessible care, inspiring global models.

Stakeholders praise: Sharma notes AI's potential ethically. Follow for impacts; York advances health equity.

Interested in mental health research? Visit York's Faculty of Health or CIHR opportunities. Share insights in comments; connect via higher ed jobs, Rate My Professor, career advice.